Engaging underrepresented individuals with Alzheimer's disease in swallowing research
Official title: CommuniTy Partnerships tO EnGagE UnderrepresenTed Persons witH AlzhEimer's Disease in Dysphagia Research (TOGETHER)
Funded at University of Wisconsin-Madison · NIH-10841340 · Data updated 2026-11-12
This study is looking for ways to help people with Alzheimer's and related dementias who have trouble swallowing by teaming up with community groups to make sure everyone gets a chance to participate, so we can find better treatments that improve their swallowing and overall well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | September 15, 2020 |
| Project end | June 30, 2025 |
| Funding year | 2023 |
| Award (this year) | $387,866 |
| NIH project number | 3K76AG068590-04S1 |
| Project ID | NIH-10841340 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Alzheimer's Disease or related dementias, particularly those from underrepresented or disadvantaged backgrounds.
✕Less likely to help
Patients who do not have Alzheimer's Disease or related dementias, or those without swallowing difficulties, may not benefit from this research.
What this research studies
This research aims to address the issue of dysphagia, or swallowing difficulties, in patients with Alzheimer's Disease and Related Dementias (AD/ADRD). It focuses on developing partnerships with community organizations to better engage underrepresented individuals who may not have access to traditional healthcare settings. By improving recruitment methods and ensuring diverse participation, the research seeks to find effective treatments that can enhance swallowing function and overall quality of life for these patients. The approach emphasizes collaboration with community resources to reach those who are often overlooked in clinical studies.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for dysphagia in Alzheimer's patients, enhancing their quality of life and reducing health complications.
How similar studies have gone: While there has been limited success in similar community-engaged approaches, this research aims to innovate by specifically targeting underrepresented populations in dysphagia research.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Rogus-Pulia, Nicole M — University of Wisconsin-Madison
- Study coordinator: Rogus-Pulia, Nicole M
Related research
Other NIH-funded projects on the same topics.
-
Swallowing changes and causes of swallowing problems in Alzheimer's disease
Following people with Alzheimer's over time to understand how their swallowing changes and what factors lead to swallowing problems.
-
Understanding swallowing difficulties in Alzheimer's disease
This study is looking at the swallowing problems that people with Alzheimer's and similar conditions often face, to understand what causes these issues and how they change over time, so we can find better ways to help manage them and prevent serious health problems.
-
Evaluating and predicting swallowing improvement in hospitalized Alzheimer's patients
This study is looking at how to help patients with Alzheimer's and related dementias who have trouble swallowing, by using a special computer program to predict which patients might get better before they leave the hospital, so that doctors can give them the best care and diet to improve their eating and overall well-b
-
Improving swallowing function in patients with Alzheimer's and related dementias
This study is looking for new ways to help people with Alzheimer's and related dementias who have trouble swallowing, by training a speech therapist to create better treatments that can make eating and drinking safer and easier for them.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.